NVONovo Nordisk

Median target
$44
calls from the last 12 months
Implied return
+1.9%
median target vs. price
Coverage
10 analysts · 11 calls
updated in the last 12 months
Consensus
0/9/1-1 net
Buy / Hold / Sell

Which analysts are behind NVO's consensus?

See every current rating, price target and the analysts' track records for Novo Nordisk — plus the full analyst rankings, firm analytics and screener.

The consensus above reflects 10 analysts with calls on NVO updated in the last 12 months. Implied return is the move implied if the consensus target were hit. These are forward-looking predictions, not realized returns. Per-analyst ratings and track records are a Premium feature.

NVO elsewhere on AnalystEdge

The most recent congressional, executive-branch and insider filings matched to this ticker. Matched by ticker symbol — occasional mismatches are possible. Not investment advice.

Trending today: #1 in Losing attention (0.3× vs usual)

DateSourceWhoActionDetailAmount
2025-10-31CongressLisa McClainMI-MI09Salesince trade -8.2%, vs market +20.5%$1K–$15K
2025-10-15CongressMarjorie Taylor GreeneGA-GA14Purchasesince trade -20.0%, vs market -35.1%$1K–$15K
2025-09-11CongressLisa McClainMI-MI09Purchasesince trade -16.4%, vs market -33.2%$1K–$15K
2025-08-28CongressMarjorie Taylor GreeneGA-GA14Purchasesince trade -19.1%, vs market -37.5%$1K–$15K
2025-08-04CongressScott Scott FranklinFL-FL18Purchasesince trade -5.9%, vs market -27.6%$15K–$50K
2025-08-04CongressScott Scott FranklinFL-FL18Purchasesince trade -5.9%, vs market -27.6%$1K–$15K
2025-08-04CongressScott Scott FranklinFL-FL18Purchasesince trade -5.9%, vs market -27.6%$1K–$15K
2025-08-04CongressLisa McClainMI-MI09Salesince trade -5.9%, vs market +27.6%$1K–$15K
2025-07-10CongressLisa McClainMI-MI09Salesince trade -35.3%, vs market +58.1%$1K–$15K
2025-06-09CongressLisa McClainMI-MI09Purchasesince trade -39.2%, vs market -67.6%$1K–$15K

More: congressional trades on NVO · insider activity · executive branch · trending